At the news
? NEUTRALIMPACT 3/10 144 filed Sep 14, 2026 at 12:14 ET
Form 144 filed by Director Jay Kunkel (via attorney-in-fact) signaling intent to sell VREX shares acquired through restricted stock vesting. The filing is an advance notice of a proposed sale, not a completed transaction, and the dollar value is undisclosed in the provided document.
- Form 144 filed by Director Jay Kunkel (via attorney-in-fact Daniel Tucci of Fidelity Brokerage Services LLC)
- Sale relates to restricted stock vesting
- Proposed sale amount not disclosed in filing
- Market cap: $777M; stock trades on Nasdaq under VREX
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access